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Background: Evidence suggests that aberrant eating may be partially motivated by the 
rewarding properties of food, in addition to caloric or metabolic need. Given the role that the 
neurotransmitter dopamine (DA) plays in the reinforcement of reward driven appetitive 
behaviors like eating, it is hypothesized that DA gene variation may contribute to the 
development of aberrant eating behavior by increasing sensitivity to signals of reward. Methods: 
A sample of midlife community volunteers from the Adult Health and Behavior Project (AHAB-
1; N = 921) were genotyped for five DA gene variants, which were summed as a cumulative risk 
score. Participants completed the Eating Disorders Inventory (EDI) to assess aberrant eating, and 
the Behavioral Activation Scale (BAS) to measure reward sensitivity. Results: Cumulative risk 
scores were not associated with presence or severity of bulimic symptoms, total BAS scores, or 
BMI, nor were total BAS scores associated with presence or severity of bulimic symptoms. The 
met allele of the COMT val/met single nucleotide polymorphism (SNP) was associated with the 
presence of bulimic symptoms and drive for thinness, as well as the severity of body 
dissatisfaction. The insertion allele of the DRD2 ins/del polymorphism was associated with 
presence of bulimic symptoms, and the severity of drive for thinness. All EDI subscales, as well 
as total BAS scores, predicted higher BMI. Discussion: Although cumulative DA risk scores 
were not associated with bulimic symptoms, COMT and DRD2 SNPs predicted several features 
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of aberrant eating, suggesting that they may increase susceptibility for aberrant eating in a 
generally healthy population. Future studies might consider examining the relationship between 
these SNPs and more proximal measures of eating behavior, such as food craving, or the size, 
frequency, and content of dietary intake, and replicating the present study in individuals with 
clinically significant aberrant eating.  
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INTRODUCTION 
Binge eating, defined as periods of excessive eating coupled with a subjective feeling of loss of 
control, and other eating episodes characterized by overeating or loss of control (referred to 
herein as “aberrant eating”) is an important clinical phenomenon. Individuals who report loss of 
control over eating demonstrate greater eating-related psychopathology, psychological 
comorbidity, and weight gain compared to those who overeat without experiencing loss of 
control (Tanofsky-Kraff & Yanovski. 2004), even among individuals without a diagnosable 
eating disorder (Vannucci, Theim, Kass, Trockel, Genkin, et al., 2013). Moreover, individuals 
who engage in binge eating are more likely than those who do not to be overweight or obese 
(Wilfley, Schwartz, Spurrell, & Fairburn, 2000; Striegel-Moore, Cachelin, Dohm, Pike, Wilfley, 
et al., 2001). These findings suggest that many of the mental and physical health consequences 
associated with clinically significant eating disorders may also be present in subclinical aberrant 
eating. Further, given that as many as 46% of obese individuals report binge eating (e.g. Spitzer, 
Yanovski, Wadden, Wing, Marcus, Stunkard, et al., 1993), it is possible that aberrant eating 
behaviors like binge eating and loss of control over eating may constitute a pathway to obesity 
for a subset of individuals. In support of this idea, prospective longitudinal research has 
demonstrated that aberrant eating is associated with more frequent weight-related cognitive 
distortions, weight gain, and weight related disease (Tanofsky-Kraff & Yanovski, 2004), 
highlighting the importance of exploring the etiological mechanisms influencing aberrant eating. 
Research has begun to reveal that motivational and reward processes, as well as the 
neurobiological pathways and neurotransmitter systems underlying these processes, may 
promote and maintain aberrant eating behavior and subsequent weight gain (Stice & Burger, 
2012; Blumenthal & Gold, 2010). Therefore, it is possible that factors thought to contribute to 
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individual differences motivational and reward processes may confer risk for aberrant eating and 
weight gain.  
1.1 REWARD PROCESSING, DOPAMINE, AND EATING 
There is increasing evidence that the drive to overeat may be partially mediated by the rewarding 
properties of food, and that such hedonic eating may be influenced by dopamine (DA) signaling 
(Lowe & Butryn, 2007). Aberrant eating, therefore, may be understood as an appetitive behavior 
that is not always related to caloric need.  DA may participate in reinforcement of food choices 
by promoting associations between palatable foods, the pleasant experience they produce, and 
the behavior that allowed the individual to obtain these foods (Wise, 2004). Reward learning is 
impaired in the presence of DA antagonists, suggesting that DA functions not to elicit the feeling 
of reward itself, but to pair that feeling with the eliciting stimulus (Wise & Schwartz, 1981). As 
such, DA may be involved in the development of taste preferences, the induction of the 
motivational state necessary to engage in aberrant eating, as well as the maintenance of 
behaviors that have been coupled with the experience of reward. Further, many of the behavioral 
features of eating disorders (e.g. dieting, purgative behaviors, exercise routines) are compulsive 
in nature (Davis & Kaptein, 2006), a feature that has been related to elevated DA processing 
(Bulik, Slof-Op’t Landt, van Furth, & Sullivan, 2007). Therefore, DA neurotransmission may be 
the key to understanding many features of disordered eating.  
Evidence from the animal literature has established that DA pathways such as the 
mesolimbic dopaminergic system (MDS; Figure 1) underlie the rewarding effects of food. In 
rats, MDS activation increases in response to food (Martel & Fantino, 1996). Following ablation 
of the DA-rich ventral tegmental area (VTA), a component of the MDS, rats no longer showed a 
preference for sucrose solution over water (Shimura, Kamada, &Yamamoto, 2002). These 
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findings suggest that the VTA is involved in developing a preference for palatable foods, as well 
as reinforcing consumption of these foods. Given the role of DA in supporting reward learning 
and appetitive motivation in animals (Nemirovsky, Avale, Brunner, & Rubinstein, 2009), altered 
DA transmission in MDS structures may influence the development of aberrant eating in humans 
by promoting stronger associations between food and its hedonic effects. 
 
 
Figure 1: Components of the MDS involved in eating behavior. Figure originally published by DiLeone, 
Taylor, & Picciotto (2012). 
 
 
1.2 DOPAMINE AND EATING: CORRESPONDANCE TO SUBSTANCE USE 
There is growing evidence that excessive food consumption may induce neural and behavioral 
changes remarkably similar to those observed in substance abuse (e.g. Avena, Rada, & Hoebel, 
2009; Stice, Spoor, Bohon, & Small, 2008; Johnson & Kenny, 2010), suggesting that factors 
thought to contribute to individual differences in substance use may also confer risk for aberrant 
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eating. For instance, rats that are intermittently given access to palatable food show binge-like 
consumption patterns, garnering 58% of their daily caloric intake from these discrete binge 
episodes despite having ad libitum access to standard chow (Avena et al., 2009). If rats exposed 
to a diet high in fat or sugar are food deprived for 24 hours, they begin to develop the types of 
withdrawal symptoms characteristically seen in both animal and human substance dependence 
(Avena et al., 2009). In addition, rats that binge eat sugar solutions have been shown to become 
more sensitive to the effects of other DA stimulants (Avena & Hoebel, 2003), providing 
evidence that binge eating produces changes in DA processing. Further, consumption of sucrose 
solutions elicits DA release in the nucleus accumbens (NAc), another region in the MDS that 
receives input from the VTA (Avena, Rada, & Hoeble, 2006). Interestingly, the elevation in DA 
occurs even during sham feeding protocols, which allow rats to ingest the sucrose solution but 
prevent it from reaching the stomach (Avena et al., 2006). This indicates that the taste of sugar 
alone can induce changes in DA transmission. Therefore, animal research demonstrating DA’s 
role in binge eating and the correspondence between neural responses to food and to drugs may 
be relevant for understanding how aberrant eating develops in humans. 
1.3 DOPAMINE AND EATING: EVIDENCE IN HUMANS 
Food-induced DA responses similar to those described in animals have also been observed in 
humans. Tasting sweet food is correlated with an elevation of synaptic concentrations of DA in 
the dorsal striatum, a subcortical region in the MDS that is densely populated by DA receptors 
(Volkow, Wang, Fowler, Logan, Jayne, et al., 2002). Further, the amount of DA released is 
proportional to self-reported hunger and desire for food (Volkow, et al., 2002). Increased DA 
activation within the MDS in response to food has been observed in obese individuals who 
frequently binge eat (Wang, Geliebter, Volkow, Telang, Logan, et al., 2011). Using food cue 
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paradigms, it has also been demonstrated that, relative to non-binge eating obese subjects, obese 
binge eaters show greater activation in the frontal and medial orbitofrontal (OFC) regions of 
cortex that receive DA input (Schienle, Schafer, Hermann, & Vaitl, 2009). Additionally, activity 
level in these regions is correlated with self-reported reward sensitivity (Schienle, et al., 2009) 
and pleasure experienced while eating (Small, Jones-Gotman, & Dagher, 2003). Notably, 
activation in these regions, particularly in the medial OFC, is thought to be involved in encoding 
the reward value of reinforcing stimuli (Schienle et al., 2009). Further, these prefrontal regions 
are innervated by fibers originating in the VTA (Fig. 1) and are densely populated with DA 
receptors (Sawaguchi & Goldman-Rakic, 1991; Wang, Zhong, Gu, & Yan, 2003; Laviolette, 
Lipski, & Grace, 2005), suggesting that frontal region responses to food may be elicited by MDS 
activation (Wang et al., 2011). These findings provide evidence that DA transmission is involved 
in the regulation of eating behavior, and may be important for understanding aberrant eating. 
Research supports the hypothesis that signaling variation within DA-rich regions 
contributes to individual differences in aberrant eating, with weight gain being a secondary 
consequence. For example, striatal DA release increases following food presentation in obese 
binge eaters. However, this pattern is not observed in non-binge eating obese subjects, 
suggesting that striatal activity may be uniquely related to binge eating (Wang et al., 2011), 
supporting the link between DA variation and aberrant eating. In fact, food cues only elicited 
excess DA release in the non-binge eating obese group after administration of methylphenidate, a 
compound that blocks reuptake of DA from the synapse (Wang et al., 2011). This indicates that 
DA processing within the striatum may participate specifically in the development of binge 
eating behavior. Therefore, DA signaling may only be indirectly related to weight gain through 
its effects on aberrant eating, a hypothesis supported by research in animals. In rat models of 
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binge eating, surges in extracellular DA within the NAc following a meal are evident in rats that 
have developed binge-like food intake patterns (Rada, Avena, & Hoebel, 2005), even in response 
to foods that are no longer novel. Conversely, DA release in response to familiar foods 
diminishes over time in rats that do not display binge eating behavior (Rada et al., 2005). This 
suggests that DA signaling is important to consider in the context of aberrant, rather than 
normative, eating behavior.  
Further, binge eating induced changes in DA signaling have been associated with 
enhanced responsivity to cues of impending food reward, particularly following a period of 
dietary restriction (Avena, 2007). Rats with restricted access to a sugar solution exhibit enhanced 
DA release in the NaC and altered DA receptor binding (Avena, 2007). Further, rats conditioned 
to lever press to obtain food show increased frequency of lever pressing following a period of 
abstinence, suggesting motivation to consume palatable foods is greater under conditions of 
restricted access (Avena, Long, & Hoebel, 2005). The increase in motivational drive to eat after 
a period of abstinence observed in binge eating rats is analogous to the pattern of human eating 
behavior in anorexia nervosa (AN), BN, and BED. Dietary restraint is considered an important 
predictor of aberrant eating (Fairburn, Cooper, & Shafran, 2003), and mediates the effect of drive 
for thinness and body dissatisfaction on subsequent episodes of aberrant eating (Stice, Shaw, & 
Nemeroff, 1998; Wilfley, et al., 2000). Therefore, changes in DA signaling enhance motivation 
to eat following dietary restraint, and may account for the relationship between weight-related 
cognitive distortions and aberrant eating. Together, these data suggest that variation in DA 
processing is involved in aberrant, rather than normative, eating, and may underlie 
symptomatology shared among eating disorder subtypes.  
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In addition to MDS signaling, DA receptor functioning is also important in the regulation 
of eating behavior. Repeated activation of receptors that are part of the DA D2 subtype, a family 
of receptors that initiate an inhibitory intracellular cascade when bound to DA, has been 
associated with aberrant eating and weight gain. For instance, D2 receptor antagonists precipitate 
hyperphagia and subsequent weight gain in animals and humans (Allison, Mentore, Heo, 
Chandler, Cappelleri, et al., 1999; Lee & Clifton, 2002). Further, consumption of a high fat diet 
is associated with decreased expression of striatal D2 autoreceptors in rats (Johnson & Kenny, 
2010). Because D2 receptors reduce presynaptic synthesis of DA when DA is present in the 
synapse, decreased expression impairs the ability of dopaminergic cells to autoregulate DA 
transmission (Haubrich & Pflueger, 1982). Weakening of this negative feedback mechanism may 
disinhibit responses to previously learned reward cues. For example, rats that have undergone D2 
receptor knockdown more quickly display binge eating behavior compared to intact rats 
(Johnson & Kenny, 2010), indicating that receptor downregulation may precede binge eating 
rather than be the consequence of it. Similarly, reduced striatal D2 receptor availability is 
associated with increased BMI in humans (Wang et al., 2001). Remarkably, this trend is reversed 
in obese patients who have undergone gastric bypass surgery. Compared to pre-surgery baseline 
of D2 receptor density, patients show increased D2 expression following surgery, when food 
intake is significantly reduced (Steele, Prokopowicz, Schweitzer, Magunsuon, Lidor, et al., 
2010). These associations indicate that individual differences in DA receptor density may 
increase risk for weight gain by influencing food preference and intake patterns. Therefore, 
genetic variation associated with differential expression of DA receptors may contribute to 
individual differences in aberrant eating behavior. 
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1.4 DOPAMINE GENE VARIATION AND EATING 
Research has demonstrated that DA gene variation is related to MDS function and aberrant 
eating, and may contribute to variation in risk for aberrant eating. Polymorphisms in genes 
regulating the degradation of synaptic DA as well as the expression and function of DA receptors 
have been linked with aberrant eating and/or MDS disturbances (see Table 1 for a summary of 
DA gene polymorphism studies and findings). 
 
 
Table 1. Summary of DA gene polymorphism studies and findings 
Polymorphism Authors Sample Findings 
DRD4 VNTR Sobik et al., 2005 
 
Sobik et al., 2005 
 
 
 
Kaplan et al., 2007 
 
Levitan et al., 2004 
 
Levitan et al., 2004 
 
Bachner-Melman et al., 
2007 
 
 
 
 
Ebstein et al., 1996 
Pogue-Geile et al., 1998 
48 healthy multi-
ethnic population 
31 female multi-
ethnic population 
with sub-clinical 
binge eating 
163 Caucasian 
females with BN 
131 Caucasian 
females with SAD 
108 Caucasian 
females with SAD 
620 Israeli females 
including those 
with AN and 
controls 
 
 
107 healthy Israeli 
individuals 
281 healthy 
Caucasian twins 
(+) 7R allele associated with 
elevated food craving 
(+) 7R associated with more 
drastic decline in craving over 
repeated presentations of food 
 
(+) 7R associated with BMI 
 
(+) 7R associated with binge 
eating 
 
(+) 7R associated with maximal 
lifetime BMI 
(+) 7R associated with drive for 
thinness among healthy controls 
(+) 7R preferentially transmitted 
with other DA gene risk variants 
in AN participants 
(+) 7R associated with novelty 
seeking 
(-) 7R not associated with novelty 
seeking 
DRD2 Taq1Aa  Stice et al., 2008 
 
Epstein et al., 2007 
 
 
Noble, 2000 
 
 
43  healthy 
Caucasian females 
74 multi-ethnic 
obese and non-
obese sample 
73 multi-ethnic 
obese sample 
 
(+) A1 allele associated with 
reduced D2 receptor density and 
BMI 
(+) A1 allele associated with 
greater food reinforcement and 
carbohydrate consumption 
(+) A1 allele associated with 
carbohydrate craving and 
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Davis et al., 2008 
 
 
Epstein et al., 2004 
 
Stice et al., 2008 
 
Epstein et al., 2007 
 
 
Davis et al., 2008 
 
 
 
Nikolova et al., 2011 
166 multi-ethnic 
individuals with 
BED and/or obesity 
88 Caucasian 
smokers 
43  healthy 
Caucasian females 
74 multi-ethnic 
obese and non-
obese individuals 
230 multi-ethnic 
individuals with 
BED and/or obesity 
69 healthy 
Caucasian 
individuals 
consumption 
(+) A1 allele associated with BED 
and reward sensitivity 
 
(+) A1 allele associated with food 
reinforcement and food intake 
(-) A1 allele not associated with 
increased MDS activation  
(-) A1 allele not associated with 
binge eating 
 
(-) A1 allele not associated with 
BED 
 
 
(-)A1 allele not associated with 
ventral striatal activation 
DRD2 ins/del Lencz et al., 2010 
 
 
Nikolova et al., 2001 
 
Davis et al., 2008 
 
 
Davis et al., 2012 
58 multi-ethnic 
individuals with 
Schizophrenia 
69 healthy 
Caucasian 
individuals 
56 multi-ethnic 
individuals with 
BED and/or obesity 
230 multi-ethnic 
individuals with 
BED and/or obesity 
 
(+) Del allele associated with 
weight gain following D2 receptor 
blockade 
 
(+) Del allele associated with 
ventral striatal activation 
(-) Del allele not associated with 
BED 
 
 
(-) Del allele not associated with 
BED 
DAT1 VNTR Shinohara et al., 2009 
 
 
 
 
Davis et al., 2007 
 
 
 
Dreher et al., 2009 
 
 
Epstein et al., 2004 
205 Japanese 
individuals 
including those 
with an eating 
disorder and 
healthy controls 
78 multi-ethnic 
individuals 
including those 
with BED and 
matched controls 
22 healthy multi-
ethnic individuals 
 
88 Caucasian 
smokers 
(+) 9R allele associated with binge 
eating among participants with an 
eating disorder 
 
 
(+) 9R allele associated with 
decreased appetite in response to 
methylphenidate 
 
(+) 9R associated with ventral 
striatal and orbitofrontal activation 
following food reward 
(-) 10R associated with greater 
food reinforcement and food 
intake 
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COMT 
Val158Met 
Dreher et al., 2009 
 
 
Frieling et al., 2006 
 
 
 
Yilmaz et al., 2011 
 
 
 
 
 
 
 
 
Groleau et al., 2012 
 
 
 
Mikolajczyk et al., 2010 
27 healthy multi-
ethnic individuals 
 
45 female 
inpatients with an 
eating disorder 
(ethnicity not 
reported) 
75 females with BN 
and 148 unaffected 
relatives (ethnicity 
not reported) 
 
166 females with 
Bulimia and 166 
ethnicity matched 
control females 
216 females with 
threshold and 
subthreshold 
bulimia (96.7% 
Caucasian) 
104 females with an 
eating disorder (61 
with Anorexia, 43 
with Bulimia; 
ethnicity not 
reported) 
(+) met allele associated with 
ventral striatal and orbitofrontal 
activation following food reward 
(+) met allele associated with 
higher EDI, Bulimia, and impulse 
regulation scores 
 
(+) met allele preferentially 
transmitted from parents to 
offspring with Bulimia 
 
 
(-) no association between COMT 
genotype and Bulimia 
 
 
(-) met allele associated with 
decreased binge frequency 
 
 
(-) val allele associated with 
Bulimia 
aA1 is the designation for the minor T allele for Taq1A genotype. 
 
Aberrant eating has been associated with D4 receptor density. The D4 receptor is heavily 
expressed in the prefrontal cortex (PFC; Fig. 1; Mrzljak, Bergson, Pappy, Huff, Levenson et al., 
1996), an area of the brain that participates in monitoring the delivery of an expected reward 
(Wantanabe, 1996; Knutson, Fong, Bennett, Adams, & Hommer, 2003).  A 48 base pair 
functional variable number of tandem repeats (VNTR) polymorphism in the DA receptor 4 
(DRD4) gene is related to D4 function (Van tol, Bunzow, Guan, Sunhara, Seeman, et al. 1992). 
The number of repeats corresponds to the relative ability of DA to bind to the D4 receptor (Van 
tol, et al. 1992). The 7-repeat (7R) allele has been associated with decreased affinity for DA 
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(Asghari, Sanyal, Buchwaldt, Paterson, Jovanovic, et al., 1995), as well as reduced signal 
transduction within cells expressing the D4 receptor (Chang et al., 1996). As a subtype of the 
D2-family of DA receptors, D4 stimulation initiates an intracellular cascade that inhibits DA 
release into the synapse (Asghari et al., 1995). However, this cascade is impaired in individuals 
with the 7R allele, resulting in an attenuated inhibitory signal in these cells. Therefore, the 7R 
allele may alter reward processing through reduced DA binding affinity to the D4 receptor or 
reduced intracellular signaling. Further, the 7R allele is associated with reduced D4 expression in 
the PFC (Asghari et al., 1995), which may impair top-down control of previously learned 
responses to rewarding stimuli (Wise et al., 2004). Individuals with the 7R allele may be more 
responsive to rewarding stimuli like food and have less inhibitory control over eating behavior 
(Wise 2004), suggesting a mechanism by which 7R carriers may be at higher risk for aberrant 
eating. Therefore, DRD4 variation may be an important factor for understanding aberrant eating. 
Research has demonstrated that DRD4 variation is associated with individual differences 
in reward function, weight, and aberrant eating. Mice that have undergone D4 knockdown were 
found to display more efficient reward learning relative to their intact counterparts (Nemirovsky 
et al., 2009). Specifically, the knockdown mice more quickly learned to associate environmental 
cues with the receipt of a food relative to wildtype mice (Nemirovsky et al., 2009). In humans, 
the 7R allele has been associated with novelty seeking (Ebstein, Novick, Umansky, Priel, Osher, 
et al., 1996; Benjamin, Li, Patterson, Greenberg, Murphy, & Hamer, 1996; Munafo, Yalcin, 
Willis-Owen, & Flint, 2007; however, see Schinka, Letsch, & Crawford, 2002 and Pogue-Geile, 
Ferrell, Deka, Debski, & Manuck, 1998) and impulsivity (Munafo et al., 2007; Eisenberg, 
MacKillop, Modi, Beauchemin, Dang et al., 2007), personality traits that are similar to reward 
sensitivity. 7R allele carriers are more reactive to food cues and report more intense craving for 
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food following cue presentation relative to non-7R carriers (Sobik, Hutchison, & Craighead, 
2005). Further, women with BN who are carriers of the 7R variant have higher BMI compared to 
non-7R carriers with BN (Kaplan et al., 2008). In women with seasonal affective disorder 
(SAD), a mood disorder characterized by seasonal binge eating and weight gain, 7R allele 
carriers are more likely to exhibit binge-eating behavior across their lifespan (Levitan, Masellis, 
Basile, Lam, Kaplan, et al., 2004). Therefore, the 7R allele may be an important factor in 
aberrant eating, and weight gain. 
In addition to the DRD4 VNTR, research has also identified a relationship between the 
Taq1A single nucleotide polymorphism (SNP) and individual differences in eating behavior. 
Taq1A lies within a genomic region downstream of the D2 receptor gene (DRD2), and may 
regulate DRD2 expression (Neville, Johnstone, & Walton, 2004). The Taq1A minor A1 allele is 
associated with reduced striatal D2 density (Noble, 2000), and DA binding affinity at the D2 
receptor (Jonsson et al., 1999). Decreased D2 expression associated with the A1 allele yields a 
weaker inhibitory signal when DA is present in the synapse, blunting the negative feedback 
mechanism that normally inhibits further DA release. Therefore, more DA is available to 
produce stronger coupling between food and the pleasure derived from eating. The A1 allele may 
be related to increased risk for aberrant eating by strengthening the association between food and 
subsequent experience of pleasure (Wise, 2004). Therefore, Taq1A variation may contribute to 
individual differences in aberrant eating behavior. 
Taq1A has been associated with eating behavior and weight gain (e.g. Wang et al., 2001; 
Steele et al., 2010). It was shown that obese individuals with the A1 allele exhibited a 30-40% 
reduction in D2 receptor availability, as well as reduced dorsal striatal activity in response to 
ingestion of palatable foods (Stice et al., 2008). Further, A1 allele carriers had significantly 
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increased BMI at one year follow-up compared to individuals who did not possess the risk allele 
(Stice et al., 2008). Therefore, A1 allele carriers showed reduced striatal D2 density, reduced 
dorsal striatal activity in response to food cues, and higher BMI, all of which suggests that the 
A1 allele increases risk for aberrant eating. A1 allele carriers have also been shown to respond 
more strongly to behavioral reinforcement when food rewards were used as the reinforcing 
stimulus. Stronger reinforcement in turn predicted elevated consumption of carbohydrate-dense 
food when given free access (Epstein, Temple, Neiderhiser, Salis, Erbe et al., 2007), indicating 
that A1 carriers may eat larger portions of food more frequently, which may then produce weight 
gain. Additionally, those who showed a preference for palatable foods rich in carbohydrates had 
a higher frequency of the A1 allele compared to those who did not prefer these foods (Noble, 
2000). Moreover, the A1 allele was associated with reward sensitivity among individuals with 
BED (Davis, Levitan, Kaplan, Carter, Reid et al., 2008). Such findings suggest that, due to low 
D2 receptor density, cues signaling impending food reward may be more salient for individuals 
carrying the A1 allele. This may then promote food preferences and patterns of eating that are 
more likely to result in aberrant eating and weight gain. As such, the Taq1A polymorphism may 
be a good candidate for studies measuring genetic risk factors for aberrant eating. 
There is evidence to suggest that a functional insertion/deletion polymorphism (-141 
ins/del) lying within the promoter region of the DRD2 gene might also increase risk for aberrant 
eating. The deletion allele, which codes for the deletion of a cytosine from the DNA sequence, 
has been associated with reduced D2 expression (Arinami et al., 1997). Several studies have 
demonstrated an association between the deletion allele and activity in the ventral striatum, a 
component of the MDS (Forbes et al., 2009; Nikolova et al., 2011). Specifically, individuals with 
the deletion allele showed elevated ventral striatal reactivity relative to insertion allele carriers 
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during an fMRI paradigm known to engage reward circuitry, suggesting that decreased D2 
density observed in the presence of the deletion allele produces deficits in inhibitory signaling in 
the ventral striatum (Hariri, Brown, Williamson, Flory, de Wit et al., 2006).  Further, in patients 
with Schizophrenia who are prescribed antipsychotic medications known to induce weight gain 
through DA receptor blockade (Lee & Clifton, 2002), deletion allele carriers gained significantly 
more weight over the course of treatment relative to individuals homozygous for the insertion 
allele (Lencz, Robinson, Napolitano, Sevy, Kane et al., 2010).  Therefore, the deletion allele may 
confer risk for weight gain by reducing D2 receptor density in MDS regions. Although this SNP 
has yet to be studied in the context of aberrant eating, its relationship to striatal receptor 
expression and to MDS activity supports doing so. 
In addition to DA receptor gene variation, evidence suggests that genes regulating DA 
availability in the synapse may also have a significant impact on responsivity to food reward 
(e.g. Volkow et al., 2002), prompting researchers to test whether variation in DA transporter 
(DAT) density is associated with individual differences in eating behavior. DAT, which is highly 
expressed in the striatal region of the MDS, participates in reuptake of excess synaptic DA 
(Davis, Levitan, Kaplan, Carter, Reid et al., 2007). As such, DAT is integrally involved in 
regulating synaptic concentrations of DA. Functionally, reduced DAT density leads to increased 
synaptic concentrations of DA. Therefore, DAT may contribute to overeating and weight gain 
through modulation of DA availability. Consistent with this hypothesis, DAT mRNA levels and 
protein expression have been shown to increase in binge-eating rats (Bello, Sweigart, Lakoski, 
Norgren, & Hajnal, 2003). In humans, elevated DAT expression was associated with BMI 
healthy volunteers (Chen, Yang, Yeh, Lee, Yao, Chiu et al., 2008). Together, such findings 
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indicate that genetic variation associated with differential expression of the DAT protein may be 
related to risk for aberrant eating and weight gain. 
Investigators have determined that aberrant eating behavior is associated with a VNTR 
located within the 3’ untranslated region of the DAT gene (DAT1). This VNTR is associated 
with differential expression of DAT, with the 10 repeat (10R) allele producing an estimated 50% 
increase in DAT density relative to the 9 repeat (9R) allele (VanNess et al., 2005). In an 
experiment in which participants chose between completing tasks to receive a favorite snack and 
completing tasks to receive a monetary reward, individuals homozygous for the 10R allele 
demonstrated a greater willingness to work for food, suggesting that they found food to be a 
more potent reinforcer (Epstein, Wright, Paluch, Leddy, Hawk et al., 2004). Further, 10R 
homozygotes who were strongly reinforced by food consumed more calories when given 
unrestricted access to food (Epstein et al., 2004). However, the opposite effect was reported in a 
sample of Japanese women diagnosed with an eating disorder, with  9R carriers exhibiting more 
binge eating behavior than 10R carriers (Shinohara, Mizushima, Hirano, Shioe, Nakazawa et al., 
2004), a finding that is more consistent with other studies examining how DAT expression 
relates to eating disorder risk. For instance, the promoter region of DAT1 was shown to be 
hypermethylated in patients with BN, indicating that DAT expression may be lower in 
individuals with BN due to suppressed transcription of DAT1 (Frieling, Romer, Scholz, 
Mittelbach, Wilhelm et al., 2009). It is possible that, due to elevated synaptic concentrations of 
DA, the reinforcement value of food is enhanced in individuals who possess the 9R allele (Davis 
et al., 2007). Despite inconsistencies in the literature, the 9R allele of the DAT VNTR has been 
more frequently associated with risk for aberrant eating, although this may reflect publication 
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bias. These findings support the role of DAT genetic variation in the modulation of reward 
system sensitivity and individual susceptibility for aberrant eating and weight gain. 
In addition to DAT, other mechanisms by which synaptic DA concentrations are 
regulated have been linked to dopaminergic processing and eating behavior. For example, the 
catechol-O-methyltransferase (COMT) enzyme has been shown to play an important role in 
terminating the action of extracellular DA following release from presynaptic terminals (Chen, 
Lipska, Halim, Ma, Matsumoto et al., 2004). Unlike DAT, COMT expression is most abundant 
in the PFC (Dreher, Kohn, Kolachana, Weinberger, & Berman, 2009), a region strongly 
innervated by MDS structures that participates in response inhibition and reward-related 
contingency learning (Ridderinkhof, van der Wildenberger, Segalowitz, & Carter, 2004). 
Presumably, variation in dopaminergic activity in the PFC would contribute to variation in the 
ability to form associations between a stimulus like food and the positive affective response the 
stimulus produces. Individuals who associate food more strongly with the experience of pleasure 
may be at greater risk for aberrant eating, and the strength of this association appears to be 
strongly dependent on dopaminergic processing. Consistent with the function of COMT, 
research has demonstrated that cortical DA levels are significantly higher in COMT knockout 
mice relative to wild-type controls (Gogos et al., 1998). Hypothetically, COMT may contribute 
to variation in eating behavior through its effects on extracellular DA levels. Therefore, genetic 
variation in the COMT gene may predict individual differences in aberrant eating. 
In humans, a functional SNP that codes for an amino acid substitution at codon 158 of the 
COMT gene is associated with increased risk for eating disorders (val158met; Frieling, Romer, 
Wilhelm, Hillemacher, Kornhuber et al., 2006). Specifically, enzymatic activity in individuals 
homozygous for the methionine (met) allele is reduced by 25-75% compared to valine (val) 
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carriers (Chen et al., 2004; Lachman, Papolos, Saito, Yu, Szumlanski et al., 1996). Lower 
enzymatic activity may produce elevated synaptic DA levels, enhancing DA mediated sensitivity 
to reward cues (Dreher et al., 2009). It is expected that carriers of the low activity met allele 
would be more responsive to food cues (Dreher et al., 2009), thus increasing their risk for 
aberrant eating. Consistent with this hypothesis, the low activity met allele has been associated 
with greater activation in the ventral striatum during anticipation of food reward, and in the 
orbitofrontal region of the PFC following delivery of a reward (Dreher et al., 2009). Importantly, 
the orbitofrontal region is thought to be involved both in the encoding of stimulus reward value 
and the regulation of food intake (Kringelbach, 2005). Met allele carriers with a diagnosed eating 
disorder have also been shown to score higher on self-report bulimia scales relative to val 
homozygotes (Frieling, et al., 2006), although it is unknown if this relationship reflects increased 
susceptibility to aberrant eating generally or to binge eating specifically. In addition, there is 
evidence to suggest that the met allele is preferentially transmitted to female probands with BN 
(Yilmaz, Kaplan, Zai, Levitan, & Kennedy, 2011). However, it should be noted that others have 
documented an association between the val allele and BN (Mikolajczyk, Grzywacz, & 
Samochowiec, 2010), highlighting inconsistencies in the literature. Nevertheless, the importance 
of the orbitofrontal cortex in the facilitation of reward learning, and the primary role that COMT 
plays in the degradation of DA in this region, suggest that variation in COMT activity could 
hypothetically influence reward processing and abnormal eating behavior. Therefore, the 
val158met SNP was genotyped in the present study.  
With the incorporation of the COMT val/met SNP, five polymorphisms have been 
identified as candidates for increased risk of aberrant eating, and possibly higher BMI. By 
examining the aggregate effect of all five polymorphisms, the current proposal aims to improve 
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upon candidate gene studies by capturing a greater proportion of the variance in eating behavior 
that is attributable to DA gene variation using a cumulative genetic risk score approach. 
1.5 CUMULATIVE GENETIC RISK SCORES 
Although gene association studies examining the effect of a single polymorphism have provided 
important clues about the neurobiological processes involved in maintaining pathological eating 
behavior, it is clear that conditions like eating disorders are quantitative in nature and likely to be 
influenced by many genes (Plomin, Haworth, & Davis, 2009). Much of the available research 
investigating the effects of genetic variation on individual differences in complex behavior like 
eating have either relied on the single locus candidate gene approach (e.g. Davis et al., 2007; 
Levitan et a., 2004; Shinohara et al., 2004), or have examined the effects of several different 
polymorphisms independently of one another (e.g. Davis et al., 2008; Frieling et al., 2006). 
Although these strategies have suggested possible pathways through which genetic variation may 
produce differences in food intake and aberrant eating, they do not adequately capture the 
complexity of the systems involved in the regulation of eating. Given the probability that eating 
behavior is influenced by multiple genes, it is unlikely that a single gene variant will explain a 
significant proportion of phenotypic variability. A more informative approach is to examine the 
aggregate effect of multiple functional polymorphisms known to contribute to signaling variation 
within relevant pathways (Nikolova et al., 2011). Studies have demonstrated the utility of 
creating multilocus genetic risk scores to explain differences in MDS reactivity during 
anticipation of a reward. For instance, cumulative genetic risk scores representing susceptibility 
for elevated dopaminergic neurotransmission were shown to significantly predict ventral striatal 
activation above and beyond any single gene variant included in the risk scores, despite the fact 
that none of the individual polymorphisms were independently significant (Nikolova et al., 
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2011). Therefore, creating a genetic risk score reflecting the aggregate effect of multiple genes 
may be more powerful for exploring neurobiological mechanisms underlying complex polygenic 
phenotypes than single-gene approaches. Applying the cumulative genetic risk score approach to 
the study of aberrant eating behavior thus has the potential to substantiate and extend upon 
research linking MDS activation to the regulation of eating behavior by identifying an 
underlying etiological mechanism, aggregate DA gene variation (Figure 2). 
1.6 GREY’S BEHAVIORAL ACTIVATION SYSTEM, DOPAMINE, AND 
APPETITIVE MOTIVATION 
Sensitivity to reward is a pertinent construct for understanding individual differences in reward-
driven behavior, and may be an important factor mediating the relationship between DA gene 
variation and aberrant eating. Based on research conducted primarily in rodents, Gray proposed 
two complementary neurobiological systems thought to underlie individual differences in 
personality, motivation, and appetitive behavior (Gray, 1990). Within this framework, processes 
such as attention, arousal, and anxiety are regulated by the Behavioral Inhibition System (BIS), 
whereas motivated and appetitive behaviors arise from activity in the Behavioral Activation 
System (BAS; Gray, 1990). Gray further implicated the dopaminergic MDS as the 
neuroanatomical origin of the BAS (Gray, 1987), making it a particularly relevant construct for 
the study of the relationship between DA and eating behavior. Theoretically, DA gene variation 
affects sensitivity to cues signaling reward, including those related to food, thereby influencing 
individual risk for aberrant eating.  
The Behavioral Inhibition Scale/Behavioral Activation Scale (BIS/BAS; Carver & White, 
1994), developed to translate Grey’s research to humans, contains a behavioral activation 
subscale featuring a series of self-referent statements that are thought to reflect sensitivity to 
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reward. The BIS/BAS has been successfully utilized to explore the relationship between eating 
behavior and responsivity to reward cues. Although the BIS/BAS has never been used in the 
context of a multilocus cumulative risk study of aberrant eating, previous studies have examined 
how dopaminergic signaling might be related to appetitive motivation or propensity to overeat. 
These studies provide a rationale for testing the relationship between mutilocus DA gene 
variation, BAS sensitivity, and aberrant eating behavior in the present proposal. For instance, the 
Taq1A A1 risk allele has been positively associated with BMI and sensitivity to reward as 
measured by the BAS in a sample of adults with BED (Davis et al., 2008). This suggests that 
blunted dopaminergic autoreceptor function may promote aberrant eating behavior by enhancing 
motivation to obtain and consume preferred foods (Davis et al., 2008).  
 In summary, research suggests that genetically mediated alterations in DA receptor 
function and DA availability may promote aberrant eating, weight gain, and obesity by 
enhancing sensitivity to signals of reward. Investigating the relationship between genetic 
variation impacting DA signaling and appetitive behavior has helped to promote a more 
complete understanding of the relationship between reward processing and aberrant eating. 
Though facets of reward processing have been repeatedly linked to excessive eating behavior 
and weight gain, there is a paucity of research exploring these effects in healthy individuals. It is 
possible that binge eating behavior is one of many risk factors for weight gain and obesity, even 
among individuals without a clinically significant eating disorder like BN or BED. Therefore, it 
is important to examine factors that influence individual risk for binge eating behavior in non-
clinical samples. Establishing that DA gene variation impacts aberrant eating in a healthy sample 
would provide evidence that variability in the DA system influences eating and subsequent 
weight gain independently of other physical or mental health factors. The present study aims to 
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extend previous research by examining the cumulative effect of variation in multiple genes 
regulating DA function on aberrant eating behavior and BMI in a sample of healthy adults. 
Additionally, in an effort to provide evidence for a possible pathway through which DA gene 
variants might elevate risk for aberrant eating, the present study will test whether the association 
between these gene variants and aberrant eating is mediated by reward sensitivity. 
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2.0  RESEARCH DESIGN AND METHODS 
2.1 PARTICIPANTS 
Participants included 1295 healthy adults from the Adult Health and Behavior Project (AHAB-I), 
an extensive registry of behavioral and biological measures collected from a mid-life community 
sample recruited in Pittsburgh and surrounding regions between 2001 and 2005. AHAB 
exclusion criteria included a clinical history of neurologic illness, cardiovascular disease, 
Schizophrenia, or other psychoses. Volunteers were also excluded if they reported current use of 
use of insulin, glucocorticoid, antiarrhythmic, psychotropic, or prescription weight-loss 
medications. For the purposes of the present study, all non-Caucasian individuals were removed 
from the sample (n = 214). Of the remaining 1081 Caucasian individuals, those who had not 
been successfully genotyped for all five polymorphisms (n = 138; 12.4%; Table 2) or who were 
missing data for any of the EDI (n = 13) or BAS (n = 9) scales were removed from the sample, 
yielding a final sample size of 921.  
 
Table 2. Percentage of missing data for independent variables 
Variable Missing data (n, %) 
Behavioral Activation Scales 
       Drive 
       Fun Seeking 
       Reward Responsiveness 
Eating Disorders Inventory 
       Bulimia 
       Drive for Thinness 
       Body Dissatisfaction 
Polymorphisms 
        Taq1A 
        DRD2 ins/del 
       COMT val/met 
       DAT1 
      DRD4 
 
9 (0.08) 
9 (0.08) 
9 (0.08) 
 
13 (1.2) 
13 (1.2) 
13 (1.2) 
 
48 (4.4) 
58 (5.2) 
64 (5.9) 
33 (3.1) 
48 (4.4) 
Note. Percentages are derived from the total sample of 1081 Caucasian individuals. 
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2.2 ASSESSMENTS 
 
2.2.1 Eating Disorders Inventory (EDI) 
The EDI is a 64-item multidimensional self-report measure of the cognitive and behavioral 
symptomatology typically observed in individuals diagnosed with AN and BN (Garner, 
Olmstead, & Polivy, 1983). Specifically, the EDI is comprised of 8 subscales assessing common 
dimensions of aberrant eating (Garner et al., 1983). Of these, participants completed a modified 
version of the EDI consisting of the Drive for Thinness, Bulimia, and Body Dissatisfaction 
subscales. The EDI and its subscales have been shown to possess adequate internal consistency 
(Cronbach’s ɑ ranging from 0.82 to 0.90; Garner et al., 1983), construct validity, and 
discriminant validity (Garner et al., 1983; Espelage, Mazzeo, Aggen, Quittner, Sherman, et al., 
2003). Further, the EDI has been shown to be useful for identifying at-risk individuals in healthy, 
non-clinical samples who display symptoms of either AN or BN but who do not meet full 
diagnostic criteria (Klemchuk, Hutchinson, & Frank, 1990; (Schoemaker, van Strien, & van der 
Straak, 1994; Engelsen & Laberg, 2001). Although it is possible to utilize data from these 
subscales to identify individuals at risk for clinically significant aberrant eating (Garner, 2004), 
the primary variables of interest in the present investigation are binge eating and related bulimic 
symptoms. Therefore, only scores on the Bulimia subscale of the EDI will be included in the 
primary analyses.   
 For each item on the EDI, respondents indicate on a 6-point Likert scale the extent to 
which a given statement applies to their eating-related thoughts or behavior, ranging from 
“never” to “always.” Depending on the content of the question, “always” or “never” may either 
reflect the most or the least pathological response. Typically, scores are then transformed from 
the original 6-point scale to a 3-point scale. The three choices reflecting the least pathological 
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response are scored as 0, and the remaining choices are assigned a value of 1, 2, or 3, with a 3 
corresponding to the most pathological choice for a given item (Garner, Olmstead, & Polivy, 
1983). However, in a study examining the validity of the EDI in a non-clinical sample, the 
psychometric properties of the EDI were improved when scores were not transformed to a 3-
point scale (Schoemaker, van Strien, & van der Straak, 1994). As such, the present study utilized 
untransformed scores on the Bulimia subscale for all analyses (Table 3). 
 
Table 3. Items on the Bulimia subscale of the Eating Disorders Inventory 
Item   
3 I eat when I am upset 
4 I stuff myself with food 
12 I have gone on eating binges where I have felt that I could 
not stop 
15 I think about bingeing (overeating) 
17 I eat moderately in front of others and stuff myself when 
they are gone 
19 I have the thought of trying to vomit in order to lose weight 
22 I eat or drink in secrecy 
 
 
2.2.2 Behavioral Inhibition and Behavioral Activation Scales (BIS/BAS) 
The BIS scale was not included as one of the dependent variables, as it is not thought to be 
related to DA function (Gray, 1990; Avale, Falzone, Gelman, Low, Grandy et al., 2004). The 13-
item BAS scale is comprised of three subscales, including Drive, Fun Seeking, and Reward 
Responsiveness. The Drive scale measures the degree to which respondents act towards 
achieving a desired goal. The Fun Seeking scale reflects the inclination to engage with novel, 
potentially rewarding stimuli. Finally, the Reward Responsiveness scale assesses the degree of 
pleasure experienced from a reward (Carver & White, 1994).  For each item, participants rate on 
a 4-point Likert scale the extent to which a given statement applies to them, with responses 
ranging from 1 “strongly disagree” to 4 “strongly agree.” Scores are then summed for each of the 
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13 items to yield a total BAS score, reflecting the degree to which an individual is motivated by 
reward (Carver & White, 1994). Adequate test-retest reliability was achieved for the BAS 
subscales (r=0.59 to 0.69; Carver & White, 1994). The BAS subscales were also shown to have 
satisfactory convergent and discriminant validity (Carver & White, 1994), and internal 
consistency (Cronbach’s ɑ ranging from 0.66-0.76; Carver & White, 1994). All primary analyses 
were conducted utilizing total BAS scores.  
2.2.3 Body Mass Index (BMI) 
Participants’ height and weight were measured, and used to calculate BMI 
((weight[lbs]/height[in2]) x 703). 
2.3 DNA COLLECTION AND GENOTYPING 
DNA was isolated from white blood cells using the PureGene kit (Gentra Systems, Minneapolis, 
MN, USA). All genomic regions of interest were amplified using polymerase chain reaction 
(PCR). DRD4 and DAT1 PCR products were resolved using gel electrophoresis, and visualized 
under UV illumination. The COMT val/met SNP was genotyped using florescence polarization 
(Chen, Levine, & Kwok, 1999). Both the DRD2 ins/del and Taq1A polymorphisms were 
genotyped utilizing enzymatic digestion methods. 
 Given the close proximity of the DRD2 ins/del and Taq1A polymorphisms, a 
preliminary analysis was conducted to test linkage disequilibrium (LD) between these two loci 
within the AHAB sample using the Haploview software (Barrett, Fry, Maller, & Daly, 2005). 
Results from the Haploview test of LD indicated that the DRD2 ins/del and Taq1A 
polymorphisms are not in significant LD (D’=45; r2=0; Figure 2). Therefore, both 
polymorphisms were included in the calculation of cumulative genetic risk scores.  
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Figure 2. Linkage disequilibrium plots for DRD2 ins/del and Taq1A polymorphisms generated in 
HaploView (Barret et al., 2005). 
 
 
 
 
All genotypes were recoded as dummy variables. Across loci, genotypes previously 
associated with elevated BMI, greater MDS reactivity, or eating disorder risk were assigned a 
score of one. In cases where there is evidence of an additive effect of genotype, heterozygous 
genotypes were assigned an intermediate score of 0.5. All other genotypes were coded as zero 
(Nikolova et al., 2011). Cumulative risk scores were then calculated for each individual by 
adding together the scores at each locus, with higher scores reflecting greater risk for DA-
mediated aberrant eating (Table 4). 
 
Table 4. Assignment of genetic risk scores by genotype 
Polymorphism Genotypes Score  
DRD2 -141 Ins/Del Del/Del 
Ins/Del 
Ins/Ins 
1 
1 
0 
DAT1 VNTR 
 
9/9 
9/10 
10/10 
1 
1 
0 
DRD4 VNTR 7/7 
7/any 
All others 
1 
1 
0 
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COMT Val158Met Met/Met 
Val/Met 
Val/Val 
1 
0.5 
0 
DRD2 Taq1Aa T/T 
C/T 
C/C 
1 
0.5 
0 
 
 
2.4 ANALYTIC APPROACH 
2.4.1 Hypotheses 
It is predicted that (1) individuals with higher genetic risk scores will have higher scores on the 
Bulimia subscale of the EDI (path AC), (2) individuals with higher genetic risk scores will 
have higher total BAS scores (path AB), and that (3) individuals with higher total BAS scores 
will have higher scores on the Bulimia subscale of the EDI (path BC). In addition, it is 
predicted that (4) the effect of elevated genetic risk on Bulimia subscale scores will be mediated 
by total BAS scores. Finally, it is predicted that (5) higher scores on the Bulimia subscale will be 
associated with higher BMI.  
2.4.2 Primary Analyses 
As preliminary analyses indicate that scores on the Bulimia subscale are positively skewed and 
zero-inflated, application of the Ordinary Least Squares (OLS) model is not appropriate. An 
alternative to OLS, the two-process hurdle model, accounts for positive skew by assuming a 
logistic regression model for zero vs. non-zero responses and a Poisson distribution for the non-
zero responses (Atkins & Gallop, 2007; McDowell, 2003).  Regression coefficients were 
separately estimated for comparisons of zero responses to any responses (i.e. zero Bulimia 
symptoms vs. any) and for comparisons among all non-zero responses (i.e. severity of Bulimia 
symptoms among those who endorse them; Atkins & Gallop, 2007). As such, the hurdle model 
provides a method for determining whether the factors that contribute to the occurrence of 
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Bulimia symptoms (i.e. zero symptoms vs. any) differ from those that contribute to the severity 
of Bulimia symptoms. To test the first component of the hurdle model, Bulimia scores were 
dummy coded to compare zero responses to non-zero responses. Specifically, three independent 
regression analyses were conducted to test the following hypotheses: (1) genetic risk scores 
predict presence of Bulimia symptoms (i.e. AC; Figure 3), (2) genetic risk scores predict total 
BAS scores (i.e. path AB), and (3) total BAS scores predict presence of Bulimia symptoms 
(i.e. BC). Logistic regression analyses were utilized to estimate path AC and path BC of 
the proposed mediation model, while a linear regression was utilized to estimate path AB.  
 
 
Figure 3. Model of the relationship between cumulative dopamine gene variation, reward sensitivity, and 
aberrant eating 
 
 
To test hypothesis four, the causal steps test of mediation (Baron & Kenny, 1986) was 
then utilized to estimate the effect of DA cumulative risk scores on total BAS scores and the 
effect of total BAS scores on risk for bulimic symptomatology (e.g. zero vs. any symptoms of 
Bulimia on the EDI). According to the causal steps test of mediation, the following three 
conditions must be met in order for BAS scores to qualify as a statistical mediator of the effect of 
cumulative risk scores on Bulimia scores: (1) variation in cumulative risk scores must 
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significantly predict variation in BAS scores, (2) variation in BAS scores must significantly 
predict Bulimia scores, and (3) the effect of cumulative risk scores on Bulimia scores should 
either be reduced or disappear when controlling for BAS scores (Baron & Kenny, 1986). Unlike 
the product of coefficients test of mediation (Sobel, 1982), the causal steps test is limited by the 
fact that it does not test the statistical significance of the indirect, mediated effect. However, the 
causal steps test was utilized in the present study because it may not be appropriate to apply the 
product of coefficients test to less conventional regression analyses like hurdle modeling (A. G. 
C. Wright, personal communication, February 1, 2013). For example, in one of the few studies 
that have explored the use of the product of coefficients test of mediation with alternative 
regression approaches, Coxe and Mackinnon (2010) concluded that significant bias was 
introduced into the model when utilizing the product of coefficients method to test mediation. 
Therefore, the causal steps test of mediation was utilized to determine whether BAS scores 
mediate the relationship between cumulative risk scores and Bulimia scores rather than the 
product of coefficients test. 
To test the second component of the hurdle model, one linear regression and two Poisson 
regression analyses were conducted to test the following hypotheses: (1) risk scores predict 
severity of Bulimia symptoms among individuals with non-zero scores on the Bulimia subscale 
(i.e. AC), (2) genetic risk scores predict total BAS scores (i.e. AB), and (3) total BAS scores 
predict severity of Bulimia symptoms among individuals with non-zero scores on the Bulimia 
subscale (i.e. BC). Poisson regression analyses were utilized to estimate path AC and path 
BC of the proposed mediation model, while a linear regression was utilized to estimate path 
AB.  The causal steps test of mediation (Baron & Kenny, 1986) was performed to determine 
whether BAS scores mediate the effect of cumulative risk scores on non-zero Bulimia scores. 
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Finally, to assess the fifth hypothesis, a separate linear regression analysis was performed to 
determine whether Bulimia scores predicted BMI.  
2.4.2.1 Bonferroni Correction 
To correct for possible alpha inflation due to multiple comparisons, the significance threshold 
was adjusted for all 7 primary analyses utilizing the Bonferroni method, yielding an adjusted p-
value of 0.007 (i.e. p <0.05/m, where m = 7 comparisons). 
2.4.2.2 Power Calculations 
Given 80% power and α level of .05, the present study was powered to detect a small effect (f 2 = 
0.0118) in both the AB pathway and BC pathway in the mediation analyses, suggesting that 
the study may be adequately powered to detect mediation. Although this approach may 
overestimate power for mediation given that it does not directly assess power to detect a 
mediated effect, programs designed to calculate power to detect mediation have not yet been 
developed (Kenny, 2012). 
2.4.2.3 Covariates 
In light of research demonstrating that BN prevalence rates (Rand & Kuldau, 1992) and reward 
sensitivity (Jorm et al., 1998) decline with age during adulthood, and that BMI increases with 
age (van Lenthe, Droomers, Schrijvers, & Mackenbach, 2000), all primary analyses included age 
as a covariate. In addition, given that the prevalence of aberrant eating is higher in females 
compared to males (Striegel-Moore, Rosselli, Perrin, DeBar, Terence-Wilson, et al., 2010), 
gender was controlled for in all primary analyses. Age and gender were only accounted for in 
secondary analyses if a model reached significance without covariates included. 
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2.4.3 Secondary Analyses 
2.4.3.1 Individual Polymorphisms 
To assess the amount of variance independently explained by each genetic variant, 
polymorphisms were added simultaneously to two additional regression analyses to predict total 
(1) BAS scores and (2) scores on the Bulimia subscale of the EDI.  These analyses were 
conducted to elucidate the utility of the cumulative risk score approach by determining whether 
cumulative risk scores do indeed predict significantly more variance in Bulimia and total BAS 
scores than any individual polymorphism considered alone. 
2.4.3.2 EDI Subscales 
Mediation analyses were reanalyzed substituting Bulimia subscale scores with scores on the 
Drive for Thinness and Body Dissatisfaction subscales of the EDI to determine whether DA gene 
variation and/or reward sensitivity predicted features of disordered eating other than bulimic 
symptoms. 
2.4.3.3 BAS Subscales 
Research suggests that the BAS subscales significantly predict responsivity to reward cues like 
food independently of total BAS scores (e.g. Beaver, Lawrence, van Ditzhuijzen, Davis, Woods, 
et al., 2006). Therefore, mediation analyses were reanalyzed substituting total BAS scores with 
each of the BAS subscales. 
2.4.3.4 Gender Interactions 
Exploratory analyses were also conducted to test whether gender interacts with total BAS scores 
to predict scores on the Bulimia subscale of the EDI above and beyond the main effect of gender 
on Bulimia scores. It is possible that gender may moderate the relationship between BAS total 
scores and Bulimia scores, such that elevated BAS scores predict Bulimia scores among women 
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but not men. This hypothesis was tested utilizing a second stage moderation of mediation 
hierarchical regression model (Figure 4) with the following equation: Y = b0 + bX + bM + bZ+ 
bMZ + ɛ, where X refers to cumulative risk scores, M refers to total BAS scores, Z refers to 
gender, and Y refers to Bulimia scores (Edwards & Lambert, 2007). An additional analysis was 
conducted to determine whether gender moderates the association between cumulative DA gene 
variation and Bulimia scores. This was tested with the following equation: Y = b0 + bX + bM + 
bZ+ bXZ + ɛ 
 
 
Figure 4. Second stage moderation model of mediation, whereby the mediating effect of variable M is 
moderated by variable Z. Figure originally published by Edwards & Lambert (2007). 
 
 
 
 
2.4.3.5 Gender Stratification 
To thoroughly explore the effect of gender on the relationship between cumulative risk scores 
and total BAS scores, between total BAS scores and Bulimia scores, and between cumulative 
risk scores and Bulimia scores, primary analyses were performed separately for each gender. 
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3.0  RESULTS 
3.1 SAMPLE CHARACTERISTICS 
Participants included 1295 healthy adults from the Adult Health and Behavior Project (AHAB-I), 
an extensive registry of behavioral and biological measures collected from a mid-life community 
sample recruited in Pittsburgh and surrounding regions between 2001 and 2005. AHAB 
exclusion criteria included a clinical history of neurologic illness, cardiovascular disease, 
Schizophrenia, or other psychoses. Volunteers were also excluded if they reported current use of 
use of insulin, glucocorticoid, antiarrhythmic, psychotropic, or prescription weight-loss 
medications. For the purposes of the present study, all non-Caucasian individuals were removed 
from the sample (n = 214). Of the remaining 1081 Caucasian individuals, those who had not 
been successfully genotyped for all five polymorphisms (n = 138; 12.4%; Table 2) or who were 
missing data for any of the EDI (n = 13) or BAS (n = 9) scales were removed from the sample, 
yielding a final sample size of 921.  
3.2 ALLELE FREQUENCY ASSOCIATIONS 
Allele distributions were in Hardy-Weinberg equilibrium (HWE) for Taq1A (X2 (1, 920) = 0.46, 
p = 0.50), DRD2 ins/del (X2 (1, 920) = 1.60, p = 0.20), and COMT val/met (X2 (1, 920) = 0.56, p 
= 0.45) polymorphisms. HWE for DRD4 and DAT1 VNTRs was tested using the Markov-chain 
method described by Guo & Thompson (1992; Table 5). Allele distributions for DRD4 (p = 0.98) 
and DAT1 (p = 0.071) VNTRs were in HWE. Cumulative risk scores (M = 1.67, SD = 0.91) were 
not associated with age (F (1, 920) = 0.190, p = 0.66) or gender (F (1,920) = 0.184, p = 0.67). 
Gender was significantly associated with DRD2 ins/del allele frequencies (X2 (2, 919) = 8.361, p 
= 0.02), with males being more likely to carry the deletion allele relative to females. Allele 
frequencies did not differ by gender for any of the other polymorphisms. Age was significantly 
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associated with DAT1 allele frequencies (F (2, 919) = 3.119, p = 0.05), with individuals 
homozygous for the 9R allele being older than individuals in the other DAT1 genotype groups. 
This is unlikely to be due to selective mortality attributable to the 10R allele given the age range 
of the sample. Age was not associated with allele frequencies for any of the other 
polymorphisms. Age and gender were included as covariates in all primary analyses. 
 
Table 5. Calculations of Hardy-Weinberg equilibrium 
 
Polymorphism 
 
X2 
 
p 
Minor Allele Frequency  
Observed Expected 
DRD2 1.60 
0.46 
0.56 
0.20 
0.50 
0.45 
0.11 
0.20 
0.46 
0.235 
0.296 
0.390 
Taq1A 
COMT 
 
Polymorphism 
 
S.E. 
 
p 
Risk Allele Frequency  
Observed Expected 
DAT1 
DRD4 
0.0143 
0.0034 
0.07 
0.98 
0.29 
0.18 
0.29 (9R) 
0.21 (7R) 
Note. Hardy-Weinberg Equilibrium for DAT1 and DRD4 variable number of tandem repeats was estimated using the 
Markov-chain method described in Guo & Thompson (1992). 
 
 
3.3 PRIMARY ANALYSES 
Cumulative risk scores were not associated with the presence of bulimic symptoms (aim 1; OR 
(1, 920) = 1.057, p = 0.49; Aim 1), or total BAS scores (B = 0.002, p = 0.99; Aim 2). Total BAS 
scores were not associated with presence of bulimic symptoms (OR (1, 920) = 1.021, p = 0.16; 
Aim 3). Neither cumulative risk scores (IRR (1, 250) = 0.928, p = 0.17; Aim 1) nor total BAS 
scores were associated with severity of bulimic symptoms (IRR (1, 250) = 0.992, p = 0.48; Aim 
3). Given that the conditions for mediation were not satisfied (Baron & Kenny, 1986) in either 
step of the hurdle model, the causal steps test of mediation was not conducted (Aim 4). 
 As predicted in Aim 5, Bulimia (B = 1.004, p = <0.01), Drive for Thinness (B = 
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0.409, p = <0.01), and Body Dissatisfaction (B = 0.421, p = <0.01) subscales of the EDI were 
associated with increased BMI after controlling for the effects of age and gender (Table 6). 
 
Table 6. Mean BMI among those with and without eating disorder symptomatology 
EDI subscale N M (SD) Range 
Bulimia 
     Present 
     Absent 
Drive for Thinness 
     Present 
     Absent 
Body Dissatisfaction 
     Present 
     Absent 
 
258 
660 
 
562 
356 
 
793 
125 
 
29.31 (6.21) 
26.22 (4.82) 
 
28.19 (0.24) 
25.35 (4.34) 
 
27.61 (5.49) 
23.75 (3.45) 
 
19-49 
17-52 
 
17-52 
17-49 
 
17-52 
17-41 
Note. BMI was not analyzed with EDI subscale scores dichotomized as they are above. 
 
3.4 SECONDARY ANALYSES 
3.4.1 Individual Gene Effects 
When analyzing the effect of each individual polymorphism on presence of bulimic symptoms in 
a stepwise logistic regression model, the overall model was found to be significant (X2 (7, 914) = 
13.042, p = 0.023). As expected, the overall model was improved by the inclusion of age and 
gender (X2 (6, 915) = 30.907, p = <0.001; Table 7), though the five DA polymorphisms predicted 
a significant amount of variance in the likelihood of reporting bulimic symptoms above and 
beyond the effect of age and gender (block X2 (6, 915) = 11.231, p = 0.047). Only the COMT 
val/met SNP was significantly associated with the presence of bulimic symptoms (OR (7, 914) = 
1.819, p = 0.005) such that individuals carrying the met allele were more likely to report any 
bulimic symptoms compared to non-met allele carriers. Utilizing simple contrast coding to 
compare the relative contribution of each genotype to presence of bulimic symptoms, it was 
revealed that the effect size of the val/met genotype was not significantly different from the 
 36 
effect size of the met/met genotype (OR (2, 919) = 0.821, p = 0.29). Met allele carriers were also 
significantly more likely to endorse any items on the Drive for Thinness subscale of the EDI 
when comparing the presence to absence of symptoms on this subscale (OR (1, 920) = 1.496, p = 
0.05). Follow-up analyses utilizing simple contrasts to compare each COMT genotype group 
indicated that only individuals with the met/met genotype were more likely to report drive for 
thinness relative to individuals with val/val (OR (2, 919) = 1.594, p = 0.03) and val/met 
genotypes (OR (2, 919) = 0.627, p = 0.03). Scores on the Drive for Thinness subscale of the EDI 
were not significantly different for individuals with the COMT val/val and val/met genotypes 
(OR (2, 919) = 0.950, p = 0.75). Met allele carriers were not more likely to report body 
dissatisfaction (OR (1, 920) = 1.307, p = 0.35). 
 
Table 7. Effects of individual dopamine loci on presence of bulimic symptoms 
 Block X2 p OR p 95% CI 
Block 1 
     Age 
     Gender 
Block 2 
     Taq1A 
     DRD2 ins/del 
     COMT val/met 
     DAT1 
    DRD4 
19.689 
 
 
11.218 
<0.001 
 
 
0.047 
 
0.993 
1.926 
 
0.920 
0.743 
1.819 
1.142 
1.005 
 
0.527 
<0.001 
 
0.974 
0.127 
0.005 
0.379 
0.976 
 
0.972-1.014 
1.433-2.587 
 
0.582-1.629 
0.508-1.088 
1.193-2.773 
0.850-1.534 
0.735-1.374 
 
 
 When considering all individual polymorphisms together in a single Poisson regression 
model, the overall model was not significant (Likelihood Ratio X2 (9, 248) = 8.223, p = 0.522). 
No individual polymorphism predicted severity of bulimic symptoms (Table 8). In contrast, 
COMT met allele carriers had more severe body dissatisfaction (Wald’s X2 (2, 791) = 11.527, p = 
0.003), even after adjusting for the effects of age and gender (Wald’s X2 (2, 791) = 12.160, p = 
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0.002). Specifically, the incident rate for Body Dissatisfaction scores among individuals with the 
val/val genotype was 0.820 times lower than the incident rate among individuals with the 
met/met genotype. The incident rate for Body Dissatisfaction scores among individuals with the 
val/met genotype was 0.847 times lower than the incident rate among individuals with the 
met/met genotype. The DRD2 ins/del polymorphism was significantly associated with severity of 
drive for thinness (Wald’s X2 (1, 561) = 4.559, p = 0.03). Contrary to the hypothesized direction 
of the association, the incident rate for Drive for Thinness scores among individuals homozygous 
for the insertion allele was 1.225 times higher than the incident rate among carriers of the 
presumed risk allele, the deletion allele. 
 
 
Table 8. Effects of individual dopamine loci on severity of bulimic symptoms 
Polymorphism Likelihood Ratio X2 p Wald X2 p M (SD) 
 
Age 
Gender 
     Female 
     Male 
Taq1A 
     A1/A1 
     A1/A2 
     A2/A2 
DRD2 ins/del 
     del carriers 
     ins/ins 
COMT val/met 
     val/val 
     val/met 
     met/met 
DAT1 
     9R carriers 
     10R/10R 
DRD4 
     7R carriers 
     Non-7R carriers 
8.123 0.522  
0.242 
0.111 
 
 
1.586 
 
 
 
3.006 
 
 
2.227 
 
 
 
0.126 
 
 
0.349 
 
0.623 
0.738 
 
 
0.452 
 
 
 
0.083 
 
 
0.328 
 
 
 
0.722 
 
 
0.555 
 
 
 
2.47 (1.85) 
2.41 (1.86) 
 
3.10 (2.03) 
2.40 (1.74) 
2.43 (1.89) 
 
2.11 (1.85) 
2.51 (1.96) 
 
2.42 (1.85) 
2.33 (1.80) 
2.75 (1.97) 
 
2.37 (1.56) 
2.52 (2.09) 
 
2.39 (1.64) 
2.47 (1.95) 
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3.4.2 EDI Subscales 
Neither cumulative risk scores nor total BAS scores predicted presence or severity of body 
dissatisfaction or drive for thinness (Tables 9 & 10). 
 
 
Table 9. Models predicting presence of drive for thinness and body dissatisfaction 
Drive for Thinness    
Predictor OR p 95% CI 
Cumulative risk scores 
Total BAS scores 
Total BAS scores (controlling for 
age and gender) 
1.005 
1.029 
1.023 
 
0.95 
0.04 
0.10 
 
0.869-1.162 
1.002-1.057 
0.995-1.052 
 
Body Dissatisfaction    
Predictor OR p 95% CI 
Cumulative risk scores 
Total BAS scores 
0.919 
1.011 
0.42 
0.57 
0.748-1.129 
0.974-1.050 
 
 
 
Table 10. Models predicting severity of drive for thinness and body dissatisfaction 
Drive for Thinness    
Predictor IRR p 95% CI 
Cumulative risk scores 
Total BAS scores 
0.977 
1.017 
0.54 
0.07 
0.906-1.053 
0.999-1.034 
Body Dissatisfaction    
Predictor IRR p 95% CI 
Cumulative risk scores 
Total BAS scores 
0.995 
1.003 
0.85 
0.55 
0.938-1.054 
0.992-1.014 
 
 
 
3.4.3 BAS Subscales 
Cumulative risk scores were not associated with scores on the Drive (F (1, 920) = 1.467, p = 
0.23), Fun Seeking (F (1, 920) = 0.176, p = 0.68), or Reward Responsiveness (F (1, 920) = 
0.626, p = 0.43) subscales of the BAS. None of the subscales were significantly associated with 
presence or severity of bulimic symptoms (Table 11). 
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Table 11. Association between BAS subscale scores and presence and severity of bulimic symptoms 
Presence of Bulimia Nervosa 
symptomatology     
Predictor OR p 95% CI 
Drive 
Fun Seeking 
Reward Responsiveness 
1.022 
1.057 
1.077 
0.51 
0.09 
0.07 
0.958-1.089 
0.991-1.127 
0.995-1.165 
Severity of Bulimia Nervosa 
symptomatology 
   
Predictor IRR p 95% CI 
Drive 
Fun Seeking 
Reward Responsiveness 
1.003 
0.970 
0.991 
0.90 
0.13 
0.78 
0.956-1.053 
0.932-1.009 
0.932-1.054 
 
 
3.4.4 Gender Interactions 
Cumulative risk scores did not interact with gender to predict presence (OR (1, 920) = 1.164, p = 
0.36) or severity of bulimic symptoms (IRR (1, 252) = 1.164, p = 0.40) after accounting for the 
main effect of gender on bulimic symptoms. However, cumulative risk scores interacted with 
gender to predict total BAS scores (B = -0.899, p = 0.01), above and beyond the main effects of 
both cumulative risk scores (B = 0.432, p = 0.09) and gender (B = 2.233, p = <0.01; Table 12).  
 
Table 12. Interactive model predicting total BAS scores 
Model R2 SE           Δ R2           F B 
Additive 
       Age 
       Gender 
       Cumulative Risk 
Cumulative riskXgender 
       Age 
       Gender 
       Cumulative Risk 
       Cumulative 
riskXgender 
0.017 
 
 
 
0.023 
4.97 
 
 
 
4.96 
----- 
 
 
 
0.007 
5.20** 
 
 
 
6.28* 
 
-0.08*  
0.73** 
 -0.01 
 
-0.08** 
 2.23** 
 0.43 
-0.90* 
Note. * p<0.05; ** p<0.01 
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Specifically, increasing cumulative risk scores were associated with decreasing BAS 
scores among women, while increasing cumulative risk scores were associated with increasing 
BAS scores among men (Figure 5). However, this effect was not linear across each of the 
possible values of the risk score (data for each risk score value between genders not depicted). 
Total BAS scores did not interact with gender to predict presence (OR (1, 920) = 0.985, p = 0.63) 
or severity (IRR (1, 253) = 1.011, p = 0.63) of bulimic symptoms when accounting for the main 
effects of age, gender, and total BAS scores. Cumulative risk scores did not interact with BAS 
scores to predict presence (OR (1, 920) = 0.997, p = 0.88) or severity (IRR (1, 253) = 1.008, p = 
0.50) of bulimic symptoms. Fully interactive models were also not significantly associated with 
presence or severity of bulimic symptoms.   
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Figure 5. Interaction between cumulative risk scores and gender to predict BAS scores. Note that cumulative risk 
scores were dichotomized for ease of depiction, but were not analyzed dichotomously 
 
 
 
3.4.5 Gender Stratification 
Among women, cumulative risk scores were not associated with presence of bulimic symptoms 
(OR (1, 471) = 1.131, p = 0.26), or total BAS scores (B = -0.481, p = 0.07). Total BAS scores 
were not associated with presence of bulimic symptoms (OR (1, 471) = 1.015, p = 0.45). Neither 
cumulative risk scores (IRR (1, 160) = 0.889, p = 0.10) nor total BAS scores (IRR (1, 160) = 
0.996, p = 0.81) were associated with severity of bulimic symptoms. Given that the conditions 
for mediation were not satisfied (Baron & Kenny, 1986) in either step of the hurdle model, the 
causal steps test of mediation was not conducted in women alone.  
 Among women, the COMT val/met SNP was the only individual polymorphism that 
was significantly associated with the presence of bulimic symptoms in the expected direction. 
Specifically, when coded according to the additive (OR (1, 471) = 2.380, p = <0.01), dominant 
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(OR (1, 471) = 1.953, p = <0.01), or recessive (OR (1, 471) = 1.604, p = 0.04) models of 
inheritance, the met allele was associated with greater likelihood of reporting bulimic symptoms 
relative to the val allele. The DRD2 ins/del polymorphism was significantly associated with 
severity of bulimic symptoms when coded according to the additive (Wald’s X2 (1, 160) = 
12.139, p = <0.01), dominant (IRR (1, 160) = 1.308, p = <0.01), and recessive models of 
inheritance (IRR (1, 160) = 1.868, p = <0.01). However, the association was in the direction 
opposite of that predicted, with the insertion allele being associated with higher BN scores 
relative to the deletion allele. The DRD4 VNTR was also associated with severity of bulimic 
symptoms when coded according to the additive (Wald’s X2 (1, 159) = 10.539, p = <0.01) or 
recessive (Wald’s X2 (1, 159) = 9.718, p = <0.01) model of inheritance in women alone. 
However, the severity of bulimic symptoms was greater among non-7R carriers and those with 
one copy of the 7R allele relative to women homozygous for the 7R allele. Specifically, the 
incident rate for bulimic symptoms among women with one copy of the 7R allele was 1.604 
times the incident rate among women homozygous for the 7R allele. The incident rate of bulimic 
symptoms among non-7R carriers was 1.456 times higher than the incident rate among women 
homozygous for the 7R allele. Significant individual gene effects did not change when adjusting 
for age, except that COMT was no longer associated with the presence of bulimic symptoms (OR 
(1, 471) = 1.604, p = 0.06) among women.  
Among men, original cumulative risk scores were not associated with presence of 
bulimic symptoms (OR (1, 449) = 0.1.003, p = 0.98), or total BAS scores (B = 0.460, p = 0.07). 
Total BAS scores were not associated with presence of bulimic symptoms (OR (1, 449) = 1.033, 
p = 0.18). Neither cumulative risk scores (IRR (1, 93) = 0.982, p = 0.84) nor total BAS scores 
were associated with severity of bulimic symptoms (IRR (1, 93) = 0.986, p = 0.40).  
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4.0  DISCUSSION 
Although prior research among clinical populations (e.g. Kaplan et al., 2007; Bachner-Melman et 
al., 2007; Davis et al., 2008; Epstein et al., 2007; Shinohara et al., 2009; Frieling et al., 2006; 
Yilmaz et al., 2011; Davis, Loxton, Levitan, Kaplan, Carter et al., 2013) and one healthy 
population (Nikolova et al., 2011) provided empirical justification for assessing the previously 
untested relationship between cumulative DA risk scores, aberrant eating, and reward sensitivity, 
the primary analyses of the present investigation did not find evidence to support such a 
relationship in a sample of healthy adults. Contrary to the primary hypotheses of this study, 
cumulative risk scores as originally proposed were not associated with the presence or severity of 
bulimic symptoms or total BAS scores. Furthermore, cumulative risk scores did not predict the 
presence or severity of drive for thinness or body dissatisfaction, and were not associated with 
scores on subscales of the BAS. Analyses also failed to detect a significant relationship between 
any of the BAS subscales and EDI subscales. Gender did not interact with cumulative risk scores 
or total BAS scores to predict the presence or severity of bulimic symptoms. BMI was not 
associated with cumulative risk scores, or with any individual polymorphism, contrary to 
previous findings demonstrating a relationship between BMI and Taq1A (Stice et al., 2008), and 
BMI and DRD4 (Levitan et al., 2004; Kaplan et al., 2007).  
On the other hand, all indices of aberrant eating, including symptoms of bulimia, drive 
for thinness, and body dissatisfaction, were associated with BMI, replicating previous research 
findings (Wilfley et al., 2000; Striegel-Moore et al., 2001). Further, total BAS scores were 
positively associated with BMI, supporting prior imaging research suggesting that sensitivity to 
signals of reward is associated with risk for obesity (Stice et al., 2008). Curiously, although EDI 
subscale scores and total BAS scores were associated with BMI, they were not significantly 
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associated with one another. This may be explained by the low base rate of aberrant eating as 
assessed by the EDI in the present sample. Further, the BAS does not specifically assess food-
related reward processing, and instead evaluates a more general impulsivity-related personality 
trait that likely influences many behaviors beyond dietary patterns which could promote weight 
gain. For example, it has been hypothesized that preference for immediate over delayed rewards 
may be related to individual differences in the reinforcing value of physical activity relative to 
sedentary pursuits (Epstein, 1998). In contrast, the EDI measures behaviors (e.g. purging) and 
weight-related cognitive distortions (e.g. “I am terrified of gaining weight,” “I think that my 
stomach is too big”), which are likely to be more directly related to BMI (Tanofsky-Kraff & 
Yanovski, 2004) than to reward sensitivity. Therefore, a measure that reflects food- or eating-
specific reward sensitivity might have been associated with the EDI, while the BAS was not in 
this case. 
4.1 ASSOCIATIONS BETWEEN THE COMT VAL/MET SNP AND ABERRANT 
EATING 
Several ancillary analyses revealed significant relationships that are of note. As 
evidenced by incident rate ratios (IRR) derived from Poisson regression analyses, individuals 
carrying the met allele of the COMT val158met SNP were 87% more likely than individuals with 
the val/val genotype to report bulimic symptoms. Interestingly, the COMT val/met SNP was not 
predictive of the severity of bulimic symptoms, suggesting that it may be specifically related to 
the likelihood of endorsing bulimic symptoms, but not to the severity of these symptoms once 
they develop. Similarly, met carriers were 54% more likely to report drive for thinness relative to 
non-met carriers, but there was no relationship between COMT val/met genotype and severity of 
drive for thinness. In contrast, the met allele was associated with severity of body dissatisfaction, 
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but there was no association between the COMT val/met SNP and presence of body 
dissatisfaction. Specifically, the number of symptoms endorsed by individuals homozygous for 
the val allele was about 21% lower than the number reported by individuals homozygous for the 
met allele. The number of symptoms endorsed by individuals with the val/met genotype was 
about 17% lower than the number of symptoms reported by individuals homozygous for the met 
allele. This indicates that the relationship between severity of body dissatisfaction and COMT 
val/met genotype is additive, such that body dissatisfaction increases as met allele loading 
increases, a finding that is supported by the predominant use of the additive coding scheme in 
studies evaluating the effect of the COMT val/met SNP (Table 1). It should be noted that post-
hoc power analyses demonstrated that power to detect an effect of COMT genotype on severity 
of bulimic symptoms (1- β err prob = 0.16; n = 254) and drive for thinness (1- β err prob = 0.40; 
n = 559) was low. This may be explained by the fact that sample sizes were reduced in Poisson 
analyses to include only those endorsing aberrant eating on each subscale, though the samples 
remained relatively large. Therefore, it is possible that these analyses may have reached 
significance if sample size had been increased. However, it may also be the case that the COMT 
val/met SNP is differentially related to the occurrence and severity of, various features of 
aberrant eating, a finding that may inform etiological models of aberrant eating.  
The observations that the met allele is associated with higher likelihood of reporting 
bulimic symptoms and drive for thinness are consistent with previous candidate gene studies 
examining the relationship between the COMT val/met SNP and bulimic symptoms (Frieling et 
al., 2006; Yilmaz et al., 2011). Given that the met allele is associated with reduced enzymatic 
degradation of DA in the PFC (Dreher et al., 2009), it is possible that met allele carriers are more 
responsive to rewards like food and have a greater difficulty exerting top-down control of 
 46 
behavior driven by midbrain DA activation (Carr & Sesack, 2000; Dreher et al., 2009; Yacubian, 
Sommer, Schroeder, Glascher, Kalisch et al., 2007). Furthermore, preliminary evidence 
demonstrating that impaired functional connectivity in fronto-striatal networks (Figure 1) during 
a reward processing task predicts persistence of binge eating following treatment for BED 
(Balodis, Grilo, Kober, Worhunsky, White, et al., 2013). Therefore, abnormalities in 
dopaminergic processing in prefrontal regions may contribute to risk for BN or BN-spectrum 
symptomatology through weakened coupling between prefrontal and midbrain regions, which 
may increase the frequency of impulsive dietary behaviors (e.g. bingeing, purging, excessive 
exercise). 
 Results indicated that the effects of COMT val/met genotype on bulimic symptoms and 
drive for thinness were not additive. Non-additive effects may explain the absence of a 
relationship between COMT val/met genotype and severity of these measures. An additive model 
would suggest that met allele loading would be related to the degree of eating pathology, with 
the severity of bulimic symptoms and drive for thinness increasing as the number of met alleles 
increased. However, results indicated that individuals with the met/met genotype were no more 
likely to report bulimic symptoms than were individuals with the val/met genotype. Similarly, 
Drive for Thinness scores did not differ significantly between individuals with the val/val and 
val/met genotypes. Therefore, based on the present data, it appears that there is no gradient in the 
likelihood of reporting bulimic symptoms or drive for thinness conferred on the basis of met 
allele loading, an observation that is consistent with the lack of an association with severity of 
these features of aberrant eating. 
No studies to date have specifically explored how variation in prefrontal DA availability 
might differentially contribute to severity but not occurrence of body dissatisfaction. To the 
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extent that body dissatisfaction represents body-image specific depressogenic cognitions, it is 
possible that factors that predispose individuals to depression may also increase the likelihood of 
body dissatisfaction. Although DA has been linked to depression, it is more closely related to 
behavioral control and motivation rather than depressed mood or depressogenic cognitions 
(Neslter & Carlezon, 2006). Unlike the symptoms captured on the BN and Drive for Thinness 
scales (e.g. “I stuff myself with food,” “I am preoccupied with the desire to be thinner”), 
symptoms on the Body Dissatisfaction scale are less behavioral in nature (e.g. “I think my thighs 
are too large”), and may therefore be more distally related to dopaminergic processing. 
Therefore, the effect of COMT genotype on presence of body dissatisfaction may not become 
evident unless other risk factors for depression are present, which may explain the lack of an 
association between COMT genotype and presence of body dissatisfaction in the present study. 
There is evidence that variation in the serotonin 2A (5HT2A) receptor gene predicts eating 
disorder subtype (e.g. AN-restricting type vs. AN-binge/purge type vs. BN) as well as severity of 
weight concern and eating pathology among women with a diagnosed eating disorder (Ricca, 
Nacmias, Boldrini, Cellini, di Bernardo et al., 2004). Specifically, individuals homozygous for 
the 5HT2A risk allele were more likely to meet criteria for AN-restricting type and BN, but not 
AN-binge/purge type. Further, individuals homozygous for the risk allele exhibited more severe 
eating pathology relative to other genotype groups (Ricca et al., 2004). Candidate gene studies in 
other clinical populations have also demonstrated that there may be unique genetic influences on 
susceptibility, progression, and clinical presentation of a given phenotype (e.g. Dick, Agrawal, 
Wang, Hinrichs, Bertelsen, Bucholz et al., 2007; Laucht, Becker, Frank, Schmidt, Esser et al., 
2008; Steiger & Bruce, 2008; Steiger, Fichter, Bruce, Joober, Badawi et al., 2011; Fanous, Zhou, 
Aggen, Bergen, Amdur et al., 2012). For instance, variation in the gene encoding apolipoprotein 
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1 was found to predict progression of, but not risk for, chronic kidney disease among African 
Americans (Parsa, Kao, Xie, Astoer, Li et al., 2013). Although no studies to date have 
demonstrated a differential effect of one genetic polymorphism on risk for, and severity of, a 
single symptom domain, there is research to support this as a possible outcome.  
It is possible that the relationship between the COMT val/met SNP and severity of body 
dissatisfaction may be related to neural mechanisms of affect regulation. In addition to the role of 
DA in reward learning, there is evidence that dopaminergic circuitry is also critical for 
establishing associations between negatively valenced emotional stimuli and environmental cues 
(Everitt, Cardinal, Parkinson, & Robbins, 2003; Nestler & Carlezon, 2006). Both the NAc and 
VTA are strongly innervated by the amygdala (Price, 2003; Jackson & Moghaddam, 2001), 
which in turn receives dense neural projections from regions of PFC (Jackson & Moghaddam, 
2001) where COMT is most active (Dreher et al., 2009). Inhibitory projections from the PFC to 
the amygdala are thought to reduce amygdala activation in response to emotionally arousing 
stimuli, an effect that is modulated by dopaminergic input (Rosenkrantz & Grace, 2001; 
Rosenkrantz & Grace, 2002). It is conceivable, then, that increased DA availability observed in 
met allele carriers may contribute to impaired emotion regulation (e.g. eating to improve mood), 
which may exacerbate body dissatisfaction.  Therefore, it is possible that the association between 
the met allele and severity of body dissatisfaction may be attributable to compromised top down 
regulation of behavioral responses to affectively laden environmental cues, including those 
related to binge eating. Post-hoc power analyses demonstrated that power to detect an effect of 
COMT genotype on presence of body dissatisfaction (1- β err prob = 0.98; n = 921) was 
adequate. This suggests that the failure to find an effect of COMT genotype on presence of body 
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dissatisfaction was not simply due to insufficient sample size, supporting the conclusion that 
COMT is differentially related to presence and severity of various features of aberrant eating.  
Negative affect is a robust predictor of subsequent binge eating (Haedt-Matt & Keel, 
2011; Crosby, Wonderlich, Engel, Simonich, Smyth et al., 2009), suggesting that individuals 
with BN may engage in binge eating as a way to regulate affect (Polivy & Herman, 1993). In 
support of this hypothesis, trajectory analyses of ecological momentary assessment (EMA) data 
have demonstrated that binge eating alleviates negative affect, thus reinforcing the behavior 
(Berg, Crosby, Cao, Peterson, Engel et al., 2013; Smyth, Wonderlich, Heron, Sliwinski, Crosby 
et al., 2007). The complex interactions between dopaminergic signaling, affect, and eating 
behavior may be one mechanism by which aberrant eating is maintained. Though participants in 
the present study are unlikely to develop a clinically significant eating disorder given that they 
are beyond the typical age of onset, these results suggest that variation in COMT signaling may 
affect aberrant eating, even among healthy individuals. On the other hand, in light of research 
demonstrating that certain symptoms of aberrant eating (e.g. binge eating, body dissatisfaction) 
are associated with weight gain, obesity (Wilfley et al., 2000; Striegel-Moore, et al., 2001) and 
negative affect (Stice, 2001), these findings may have important implications for determining 
who may be most susceptible to obesogenic eating behaviors and associated psychological 
distress. Future studies could use EMA techniques to determine if COMT val/met genotype is 
predictive of the trajectory of aberrant eating behaviors and their relationship to negative affect. 
If so, this information could be utilized to identify individuals in clinical settings who may 
benefit from self-monitoring and the development of alternative emotional regulation strategies. 
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4.2 ASSOCIATIONS BETWEEN THE DRD2 INS/DEL POLYMORPHISM AND 
ABERRANT EATING 
Ancillary analyses also revealed a significant association between the DRD2 ins/del 
polymorphism and severity of drive for thinness. However, the relationship was in the direction 
opposite of that predicted. Results suggested that the number of symptoms of drive for thinness 
reported by individuals homozygous for the insertion allele was 23% higher than the number 
reported by carriers of the deletion allele. Similarly, when considering women only, the insertion 
allele was associated with severity of bulimic symptoms, but not with any other symptoms of 
aberrant eating. It should be noted that only a few studies have examined this polymorphism in 
the context of aberrant eating, the findings of which are inconsistent. For instance, there is 
evidence that deletion allele predicts weight gain among individuals being treated with D2 
receptor antagonists (Lencz et al., 2010), as well as greater ventral striatal activity in response to 
monetary reward (Nikolova et al., 2011). However, studies have failed to support a relationship 
between the DRD2 ins/del polymorphism and BED (Davis et al., 2008; Davis et al., 2012). 
Furthermore, there is disagreement about the functional effect of DRD2 ins/del variation on D2 
receptor expression in the brain (Arinami et al., 1997; Jonsson et al., 1999). Methodological 
differences in the quantification of D2 receptors may explain the conflicting results, but further 
research in this area is needed. Therefore, results from the present investigation should be 
interpreted with caution, particularly given that only 16 individuals (1.7%) in the present sample 
were homozygous for the deletion allele.  
4.3 MODERATING EFFECT OF GENDER 
Based on research demonstrating that the prevalence of aberrant eating is considerably higher 
among females (Striegel-Moore et al., 2010; Hudson, Hiripi, Pope, & Kessler, 2007), it was 
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hypothesized that gender might moderate the relationships in each path of the proposed 
mediation model. Though no significant main effects of cumulative risk scores or gender were 
detected after controlling for the effect of age, analyses revealed a significant interaction between 
cumulative risk scores and gender predicting total BAS scores. Specifically, increasing 
cumulative risk scores were associated with increasing total BAS scores among men, but with 
decreasing total BAS scores among women (Figure 5). This unexpected finding could be 
explained by the fact that men are more likely than women to engage in risk taking behaviors 
(e.g. gambling, reckless driving, etc.; Fischer & Smith, 2008; Byrnes, Miller, & Schafer, 1999), 
whereas women are more likely to engage in binge eating (Fischer & Smith, 2008). BAS items 
are constructed in such a way that they better capture behaviors that may be more often endorsed 
by men (e.g. “I have very few fears when compared to my friends,” “Even if something bad is 
about to happen to me, I rarely experience fear or nervousness”; for a meta-analysis of gender 
differences in impulsivity, see Cross, Cropping, & Campbell, 2011). It is possible that men at 
higher genetic risk for personality traits related to impulsivity would achieve higher scores on the 
BAS, while women at higher genetic risk may not because they express their risk through 
behaviors not captured on the BAS (i.e., impulsive eating). Nevertheless, the finding that 
cumulative risk scores interact with gender to predict BAS scores is consistent with other studies 
demonstrating that the association between DA gene variation and reward-driven behavior is 
dependent on gender. For instance, DRD4 and DRD2 variation predict sensitivity to nicotine 
among male non-smokers, but not among women (Perkins, Lerman, Coddington, Jetton, Karelitz 
et al., 2008). Similarly, variation in the monoamine oxidase A gene has been associated with 
BMI among men, but not women (Fuemmler, Agurs-Collins, McClernon, Kollins, Kail et al., 
2008), suggesting that the genetically determined rate of enzymatic degradation of DA and other 
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monoamines is related to risk for obesity in a gender-specific way. Future studies should further 
investigate the moderating effect of gender on the relationship between DA gene variation and a 
broader range of positively valenced appetitive drives (e.g., binge eating, sensitivity to reward 
cues, behavioral or decisional impulsivity) to elucidate the potential mechanisms that might 
underlie observed gender interactions. 
4.4 LIMITATIONS AND FUTURE DIRECTIONS 
There are several factors that may potentially explain the null findings, including the low 
incidence of eating pathology, constricted variance in the EDI scores, and method of phenotype 
assessment. Given that individuals in the current sample were selected on the basis of being in 
good health, there was minimal representation of eating pathology. Therefore, the EDI may not 
have been ideal to address the study questions in this sample, a hypothesis that is supported by 
the low variance and positive skew of the data obtained from the Bulimia subscale of the EDI. 
Rather than examining the relationship between cumulative DA risk scores, reward sensitivity, 
and aberrant eating, there may have been greater statistical power to assess normative eating 
behavior, such as size, frequency, and content of dietary intake as assessed by measures such as 
the Food Frequency Questionnaire (Rimm, Giovannucci, Stampfer, Colditz, Litin, et al., 1993). 
Further, changes in dietary patterns are likely to precede the onset of a diagnosable eating 
disorder (Fairburn & Harrison, 2003), suggesting that genetic variation may have a more 
proximal influence on eating behavior that may subsequently lead to the development of eating 
disorder symptomatology (e.g. overvaluation of weight, negative expectancies about food, binge 
eating). Alternatively, study questions could have been assessed utilizing a case-control design 
with individuals diagnosed with BN to increase statistical power (Daly & Day, 2001).  
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It is possible that the use of self-report measures to assess reward sensitivity and aberrant 
eating may have led participants to underreport the degree to which they exhibit the behaviors, 
symptoms, or attributes being assessed, potentially obscuring true relationships among the 
variables under study (Podsakoff, Mackenzie, Lee, & Podsakoff, 2003). For instance, 
participants may have been reluctant to endorse items that they perceived to be socially 
undesirable (e.g. purgative behaviors, risk taking; Podsakoff et al., 2003), or may have 
underestimated the extent to which the items applied to them due to recall bias (Coughlin, 1990). 
Future studies investigating the relationship between DA gene variation, reward sensitivity, and 
aberrant eating could use a clinical interview to evaluate symptoms of BN (i.e. the Eating 
Disorder Examination, 16th ed.; Fairburn, Cooper, & O’Connor, 2008), along with behavioral 
assessments of reward-driven decision-making (e.g. delay discounting tasks; Green & Meyerson, 
2004). 
4.5 SUMMARY 
In summary, cumulative genetic risk scores were not associated with presence or severity of 
aberrant eating. Cumulative risk scores did not predict reward sensitivity, nor was reward 
sensitivity associated with any index of aberrant eating. Nevertheless, analyses revealed a 
significant overall effect of the five DA polymorphisms on the presence of bulimic symptoms 
when included in a stepwise logistic regression model above and beyond the effects of age and 
gender. This indicates that these polymorphisms predict a significant amount of variance in the 
likelihood of reporting aberrant eating.  Furthermore, the current study demonstrated that gender 
interacts with aggregated DA gene variation to predict sensitivity to reward. Although the 
present study did not find evidence that sensitivity to reward was correlated with aberrant eating 
specifically, it is possible that the moderating effect of gender on the relationship between DA 
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gene variation and sensitivity to reward may have important implications for research exploring 
gender differences in impulsivity-related phenotypes like substance abuse, food intake, and 
gambling. Furthermore, results suggested that the low activity met allele of the COMT val/met 
SNP was significantly associated with various indices of aberrant eating among healthy adults, 
consistent with prior research in populations with a diagnosed eating disorder. Specifically, the 
met allele was associated with the presence, but not the severity, of bulimic symptoms and drive 
for thinness, while being associated only with severity of body dissatisfaction. Importantly, these 
results indicate that the met allele differentially predicts presence of and severity of eating 
disorder symptomatology, a novel finding that may enrich our understanding of the mechanisms 
underlying both the development and magnitude of aberrant eating.  
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